Ensuring Access to Adequate Information on Medical Products for All
08/10/2013 10:49pm | 8168 viewsReleased July 18, 2013
The National Minority Quality Forum commends the Food and Drug Administration (FDA) on the release of the report, “Ensuring Access to Adequate Information on Medical Products for All.” This report is an important step in advancing efforts to improve the quality and effectiveness of drugs, biologics and devices in racial and ethnic populations that are underrepresented in advanced clinical research, including Hispanics/Latinos, African Americans, and Asians/Pacific Islanders. The report, which was released by FDA on July 9, 2013, was mandated by Section 1138 of the Food and Drug Administration Safety and Innovation Act (FDASIA), which was signed into law on July 9, 2012.
About the Author
The National Minority Quality Forum (The Forum) is a Washington, DC-based not-for-profit, non-partisan, independent research and education organization dedicated to improving the quality of health care that is available for and provided to all populations.